• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白杨素及其磷酸酯抑制Hela细胞的增殖并诱导其凋亡。

Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells.

作者信息

Zhang Ting, Chen Xiaolan, Qu Lingbo, Wu Jinglan, Cui Ran, Zhao Yufen

机构信息

Key Laboratory of Chemical Biology, Department of Chemistry, Zhengzhou University, Zhengzhou 450052, PR China.

出版信息

Bioorg Med Chem. 2004 Dec 1;12(23):6097-105. doi: 10.1016/j.bmc.2004.09.013.

DOI:10.1016/j.bmc.2004.09.013
PMID:15519155
Abstract

To improve the biological activities of chrysin (CR), we synthesize Diethyl Chysin-7-yl phosphate (CPE: C(19)H(19)O(7)P) and tetraethyl bis-phosphoric ester of chrysin (CP: C(23)H(28)O(10)P(2)) through a simplified Atheron-Todd reaction. The interactions of the CR and CPE with lysozyme were explored by electrospray ionization mass spectrometry (ESI) and fluorescence spectrometry method. Experimental results indicate that CPE could form the noncovalent compound with lysozyme, while the interaction of the CR with lysozyme was not detected. In addition, whether and how the compounds CPE and CP affect proliferation and apoptosis in human cervical cancer Hela cells were investigated. Moreover, the effects of CPE and CP in Hela cells were compared with that of the nonmodified CR compound. The Hela cells were co-cultured with CR, CP, and CPE as experimental groups, respectively, and corresponding control groups treated without CR, CP, and CPE. The proliferation and apoptosis were detected using MTT assay, HCl denatured-methyl green-pyronin staining, PCNA immunohistochemistry and TUNEL techniques. The cell growth IC(50), relative absorbance (RA), proliferating index (PI), PCNA-IR (immunoreactivity IR) integration value (IV), and apoptosis index (AI) were calculated and their correlation was analyzed in each group. The results show that all CR, CP, and CPE could inhibit proliferation and induce apoptosis in Hela cells. Moreover, the effects of CP and CPE were more potent than that of CR. The CP and CPE were proved to be a kind of stronger apoptosis inducers than nonphosphated CR. There was a negative correlation between proliferation and apoptosis. In conclusion, the CR, CP, and CPE could effectively inhibit growth by down-regulated expression of PCNA, and induce apoptosis in Hela cells. The efficiency of the modified CP and CPE preceded nonmodified CR compounds. The CP and CPE may be a new potential anti-cancer drug for therapy of human cervical carcinoma.

摘要

为提高白杨素(CR)的生物活性,我们通过简化的阿特隆 - 托德反应合成了白杨素 -7- 磷酸二乙酯(CPE:C(19)H(19)O(7)P)和白杨素双磷酸四乙酯(CP:C(23)H(28)O(10)P(2))。采用电喷雾电离质谱(ESI)和荧光光谱法探究了CR和CPE与溶菌酶的相互作用。实验结果表明,CPE能与溶菌酶形成非共价化合物,而未检测到CR与溶菌酶的相互作用。此外,研究了化合物CPE和CP是否以及如何影响人宫颈癌Hela细胞的增殖和凋亡。而且,将CPE和CP在Hela细胞中的作用与未修饰的CR化合物进行了比较。分别将Hela细胞与CR、CP和CPE共培养作为实验组,相应的对照组不进行CR、CP和CPE处理。使用MTT法、盐酸变性 - 甲基绿 - 派洛宁染色、PCNA免疫组织化学和TUNEL技术检测增殖和凋亡情况。计算每组的细胞生长IC(50)、相对吸光度(RA)、增殖指数(PI)、PCNA - IR(免疫反应性IR)积分值(IV)和凋亡指数(AI),并分析它们之间的相关性。结果表明,所有的CR、CP和CPE均能抑制Hela细胞增殖并诱导其凋亡。而且,CP和CPE的作用比CR更强。CP和CPE被证明是比未磷酸化的CR更强的凋亡诱导剂。增殖与凋亡之间呈负相关。总之,CR、CP和CPE可通过下调PCNA表达有效抑制生长,并诱导Hela细胞凋亡。修饰后的CP和CPE的效果优于未修饰的CR化合物。CP和CPE可能是治疗人宫颈癌的新型潜在抗癌药物。

相似文献

1
Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells.白杨素及其磷酸酯抑制Hela细胞的增殖并诱导其凋亡。
Bioorg Med Chem. 2004 Dec 1;12(23):6097-105. doi: 10.1016/j.bmc.2004.09.013.
2
Inhibitory effects and underlying mechanism of 7-hydroxyflavone phosphate ester in HeLa cells.7-羟基黄酮磷酸盐酯在 HeLa 细胞中的抑制作用及作用机制。
PLoS One. 2012;7(5):e36652. doi: 10.1371/journal.pone.0036652. Epub 2012 May 4.
3
[Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].[针对人乳头瘤病毒18 E6/E7的反义核酸靶向作用对人宫颈癌增殖和凋亡的影响:HeLa细胞的体外实验]
Zhonghua Yi Xue Za Zhi. 2007 Jun 19;87(23):1618-21.
4
[Effects of honokiol on proliferation and apoptosis of human cervical carcinoma cell line Hela in vitro].[厚朴酚对人宫颈癌Hela细胞系体外增殖和凋亡的影响]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Jul;39(4):558-62.
5
Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.生存素基因RNA干扰抑制HeLa细胞增殖、诱导凋亡并增强其放射敏感性。
Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):83-9. doi: 10.1016/j.ejogrb.2006.07.057. Epub 2006 Nov 13.
6
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.绿茶多酚及其成分表没食子儿茶素没食子酸酯在体外和体内均能抑制人乳腺癌细胞的增殖。
Cancer Lett. 2007 Jan 8;245(1-2):232-41. doi: 10.1016/j.canlet.2006.01.027. Epub 2006 Mar 6.
7
Evaluation of effects of methamphetamine repeated dosing on proliferation and apoptosis of rat germ cells.甲基苯丙胺重复给药对大鼠生殖细胞增殖和凋亡影响的评估
Syst Biol Reprod Med. 2008 Mar-Apr;54(2):85-91. doi: 10.1080/19396360801952078.
8
Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.细胞凋亡敏感性蛋白与人类肝细胞癌中的增殖
Int J Mol Med. 2006 Jul;18(1):77-81.
9
[Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].反义人端粒酶RNA与反义人端粒酶催化亚基联合抑制宫颈癌Hela细胞生长
Zhonghua Fu Chan Ke Za Zhi. 2005 Jan;40(1):42-6.
10
Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.脱氢表雄酮通过一种不依赖雄激素和雌激素受体的机制抑制人乳头瘤病毒阳性和阴性宫颈癌细胞的增殖并诱导其死亡。
FEBS J. 2009 Oct;276(19):5598-609. doi: 10.1111/j.1742-4658.2009.07253.x. Epub 2009 Aug 21.

引用本文的文献

1
Chrysin induces cell death and inhibits migration and invasion in squamous cervical carcinoma using a three-dimensional cell culture model.白杨素利用三维细胞培养模型诱导宫颈鳞状细胞癌细胞死亡,并抑制其迁移和侵袭。
Braz J Med Biol Res. 2025 Aug 29;58:e14692. doi: 10.1590/1414-431X2025e14692. eCollection 2025.
2
Research progress on the anti-cancer mechanisms of edible salty-flavored Chinese materia medica.食用咸味中药抗癌机制的研究进展
Front Pharmacol. 2025 Jun 20;16:1598978. doi: 10.3389/fphar.2025.1598978. eCollection 2025.
3
Chrysin Exhibits Selective Antiproliferative and Antimigratory Activities in a Wide Range of Human-derived Cervical Cancer Cell Lines.
白杨素在多种人源宫颈癌细胞系中表现出选择性抗增殖和抗迁移活性。
Anticancer Agents Med Chem. 2025;25(17):1311-1322. doi: 10.2174/0118715206366318250312052617.
4
Network pharmacology unveils the intricate molecular landscape of Chrysin in breast cancer therapeutics.网络药理学揭示了白杨素在乳腺癌治疗中的复杂分子图景。
Discov Oncol. 2025 Feb 23;16(1):228. doi: 10.1007/s12672-025-01951-3.
5
Discovery of a Novel Co-crystal of Chrysin and Oroxylin A with Anticancer Properties from Leaves of .从……叶子中发现具有抗癌特性的白杨素和木犀草素新型共晶体。 (你提供的原文结尾不完整,这里是根据现有内容翻译的)
Anticancer Agents Med Chem. 2025;25(8):563-573. doi: 10.2174/0118715206364530241128044041.
6
Role and regulation of FOXO3a: new insights into breast cancer therapy.FOXO3a的作用与调控:乳腺癌治疗的新见解
Front Pharmacol. 2024 Mar 4;15:1346745. doi: 10.3389/fphar.2024.1346745. eCollection 2024.
7
Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy.天然小分子调控的长链非编码 RNA 在癌症治疗中的策略和创新作用。
Curr Med Chem. 2024;31(40):6672-6691. doi: 10.2174/0109298673264372230919102758.
8
Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review.白杨素在癌症治疗中的抗癌活性:一项系统综述。
Indian J Surg Oncol. 2022 Dec;13(4):681-690. doi: 10.1007/s13193-022-01550-6. Epub 2022 May 10.
9
Chrysin impairs genomic stability by suppressing DNA double-strand break repair in breast cancer cells.白杨素通过抑制乳腺癌细胞中 DNA 双链断裂修复来损害基因组稳定性。
Cell Cycle. 2022 Feb;21(4):379-391. doi: 10.1080/15384101.2021.2020434. Epub 2022 Jan 5.
10
Chrysin induces autophagy through the inactivation of the ROS‑mediated Akt/mTOR signaling pathway in endometrial cancer.白杨素通过抑制活性氧介导的 Akt/mTOR 信号通路诱导子宫内膜癌细胞自噬。
Int J Mol Med. 2021 Sep;48(3). doi: 10.3892/ijmm.2021.5005. Epub 2021 Jul 19.